Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-29 | Bruce Wendel (3) 2021 184,086 1,122,658 1,306,744 |
| 2022-08-17 | Bruce Wendel |
| 2023-05-01 | Bruce Wendel, Vice Chairman of the Board |
| 2023-11-06 | Bruce Wendel (5) Includes shares underlying options to purchase 558,333 shares of common stock. |
| 2024-04-29 | Mr. Wendel was appointed to our Board of Directors on November 11, 2020. From April 2018 to May 2019, Mr. Wendel served as the Chief Business Development Officer for Prometic Biotherapeutics, Inc., a pharmaceutical development company. |
Data sourced from SEC filings. Last updated: 2025-08-30